Stocks and Investing
Stocks and Investing
Tue, April 10, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
PJ Juvekar Maintained (CC) at Strong Buy with Decreased Target to $66 on, Apr 10th, 2018
PJ Juvekar of Citigroup, Maintained "The Chemours Company" (CC) at Strong Buy with Decreased Target from $68 to $66 on, Apr 10th, 2018.
PJ has made no other calls on CC in the last 4 months.
There are 2 other peers that have a rating on CC. Out of the 2 peers that are also analyzing CC, 1 agrees with PJ's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vincent Andrews of "Morgan Stanley" Initiated at Hold and Held Target at $58 on, Tuesday, January 30th, 2018
This is the rating of the analyst that currently disagrees with PJ
- John McNulty of "BMO Capital" Initiated at Buy and Held Target at $68 on, Wednesday, March 28th, 2018
Contributing Sources